Autonomic modulation of arterial pressure and heart rate variability in hypertensive diabetic rats. 2007

Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
Hypertension Unit, Heart Institute, University of Sao Paulo, Medical School, Sao Paulo, Brazil.

OBJECTIVE The aim of the present study was to evaluate the autonomic modulation of the cardiovascular system in streptozotocin (STZ)-induced diabetic spontaneously hypertensive rats (SHR), evaluating baroreflex sensitivity and arterial pressure and heart rate variability. METHODS Male SHR were divided in control (SHR) and diabetic (SHR+DM, 5 days after STZ) groups. Arterial pressure (AP) and baroreflex sensitivity (evaluated by tachycardic and bradycardic responses to changes in AP) were monitored. Autoregressive spectral estimation was performed for systolic AP (SAP) and pulse interval (PI) with oscillatory components quantified as low (LF:0.2-0.6Hz) and high (HF:0.6-3.0Hz) frequency ranges. RESULTS Mean AP and heart rate in SHR+DM (131+/-3 mmHg and 276+/-6 bpm) were lower than in SHR (160+/-7 mmHg and 330+/-8 bpm). Baroreflex bradycardia was lower in SHR+DM as compared to SHR (0.55+/-0.1 vs. 0.97+/-0.1 bpm/mmHg). Overall SAP variability in the time domain (standard deviation of beat-by-beat time series of SAP) was lower in SHR+DM (3.1+/-0.2 mmHg) than in SHR (5.7+/-0.6 mmHg). The standard deviation of the PI was similar between groups. Diabetes reduced the LF of SAP (3.3+/-0.8 vs. 28.7+/-7.6 mmHg2 in SHR), while HF of SAP were unchanged. The power of oscillatory components of PI did not differ between groups. CONCLUSIONS These results show that the association of hypertension and diabetes causes an impairment of the peripheral cardiovascular sympathetic modulation that could be, at least in part, responsible for the reduction in AP levels. Moreover, this study demonstrates that diabetes might actually impair the reduced buffer function of the baroreceptors while reducing blood pressure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001341 Autonomic Nervous System The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS. Vegetative Nervous System,Visceral Nervous System,Autonomic Nervous Systems,Nervous System, Autonomic,Nervous System, Vegetative,Nervous System, Visceral,Nervous Systems, Autonomic,Nervous Systems, Vegetative,Nervous Systems, Visceral,System, Autonomic Nervous,System, Vegetative Nervous,System, Visceral Nervous,Systems, Autonomic Nervous,Systems, Vegetative Nervous,Systems, Visceral Nervous,Vegetative Nervous Systems,Visceral Nervous Systems
D013311 Streptozocin An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. Streptozotocin,2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose,Streptozotocine,Zanosar
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
May 2009, Life sciences,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
December 1987, Schweizerische medizinische Wochenschrift,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
December 2000, Diabetes, nutrition & metabolism,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
February 2000, The Journal of laboratory and clinical medicine,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
July 2001, Autonomic neuroscience : basic & clinical,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
July 1998, Clinical science (London, England : 1979),
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
August 1999, Archives des maladies du coeur et des vaisseaux,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
October 1989, Journal of hypertension,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
November 1998, International journal of cardiology,
Vera de Moura Azevedo Farah, and Kátia De Angelis, and Luis Fernando Joaquim, and Georgia O Candido, and Nathalia Bernardes, and Rubens Fazan, and Beatriz D'Agord Schaan, and Maria-Claudia Irigoyen
April 2002, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!